Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for MO and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for MO and 80,000+ other tickers.
See exactly how MO's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MO and 80,000+ other tickers.
Operating across the United States through its subsidiaries, Altria Group, Inc. is a prominent manufacturer and marketer of both combustible and oral tobacco items. Its portfolio features cigarettes, primarily under the iconic Marlboro brand, alongside cigars and pipe tobacco mainly offered as Black & Mild. The enterprise further provides an assortment of moist smokeless tobacco products, including Copenhagen, Skoal, Red Seal, and Husky, in addition to its on! brand of oral nicotine pouches. Altria distributes its merchandise chiefly to wholesale partners, such as independent distributors…
Altria (MO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
With Treasury yields north of 5%, the bar for dividend stocks has never been higher, yet five companies are clearing it with cash-covered payouts and decades of consecutive raises behind them.
Altria spent a decade writing down bad bets, watching cigarette volumes shrink, and losing ground on smoke-free products. Yet investors who stuck around still came out ahead, and the reason has almost nothing to do with the stock price.
With the 10-year Treasury now yielding above 5%, most dividend stocks no longer clear the bar. These five not only clear it but back every payout with real cash flow, and one yields nearly double what Treasuries pay.
Tobacco and pipeline giants rarely share the spotlight, but three companies spanning both sectors are quietly raising their payouts while most investors chase growth stocks that pay nothing at all.